Download PDF
Digestive Disease Interventions 2020; 04(03): 267-272
DOI: 10.1055/s-0040-1715817
Review Article

Endovascular Treatment of Malignant Portomesenteric Venous Obstruction

Nassir Rostambeigi 
1   Vascular Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
,
Michael D. Darcy 
1   Vascular Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Portal vein thrombosis (PVT) is a rare condition, and malignancies account for up to a quarter of cases. Malignant PVT is an advanced stage in the neoplastic process, which affects survival. In addition, portal venous obstruction can result in portal hypertension and associated complications. There are a few reports on the surgical and nonsurgical management of this condition. We herein aim to present an overview of these management options and discuss the factors affecting the outcomes after each. We will also discuss gaps in knowledge and the possible areas for future research.

Keywords

malignant portal vein obstruction - endovascular management - liver cirrhosis


Publication History

Received: 22 April 2020

Accepted: 24 June 2020

Article published online:
10 September 2020

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. Am J Med 1992; 92 (02) 173-182
    CrossrefPubMedGoogle Scholar
  • 2 Macpherson AI. Portal hypertension due to extrahepatic portal venous obstruction. A review of 40 cases. J R Coll Surg Edinb 1984; 29 (01) 4-10
    PubMedGoogle Scholar
  • 3 Fujii T, Takayasu K, Muramatsu Y. et al. Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993; 23 (02) 105-109
    PubMedGoogle Scholar
  • 4 Takizawa D, Kakizaki S, Sohara N. et al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 2007; 52 (11) 3290-3295
    CrossrefPubMedGoogle Scholar
  • 5 Hellman P, Hessman O, Akerström G. et al. Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses. World J Surg 2010; 34 (06) 1373-1379
    CrossrefPubMedGoogle Scholar
  • 6 Harch JM, Radin RD, Yellin AE, Donovan AJ. Pylethrombosis. Serendipitous radiologic diagnosis. Arch Surg 1987; 122 (10) 1116-1119
    CrossrefPubMedGoogle Scholar
  • 7 Villa E, Moles A, Ferretti I. et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 2000; 32 (02) 233-238
    CrossrefPubMedGoogle Scholar
  • 8 Janssen HL, Wijnhoud A, Haagsma EB. et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49 (05) 720-724
    CrossrefPubMedGoogle Scholar
  • 9 Cardarelli-Leite L, Chung J, Klass D. et al. Ablative transarterial radioembolization improves survival in patients with HCC and portal vein tumor thrombus. Cardiovasc Intervent Radiol 2020; 43 (03) 411-422
    CrossrefPubMedGoogle Scholar
  • 10 Gao R, Gabr A, Mouli S. et al. Toxicity and survival of hepatocellular carcinoma patients with hepatitis B infection treated with yttrium-90 radioembolization: an updated 15-year study. J Vasc Interv Radiol 2020; 31 (03) 401-408.e1
    CrossrefPubMedGoogle Scholar
  • 11 Zhao Y, Duran R, Chapiro J. et al. Transarterial chemoembolization for the treatment of advanced-stage hepatocellular carcinoma. J Gastrointest Surg 2016; 20 (12) 2002-2009
    CrossrefPubMedGoogle Scholar
  • 12 Kokudo T, Hasegawa K, Matsuyama Y. , et al; Liver Cancer Study Group of Japan. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol 2016; 65 (05) 938-943
    CrossrefPubMedGoogle Scholar
  • 13 Watanabe Y, Sato M, Abe Y. et al. Metallic stents for low invasive recanalization of the portal veins with cancerous invasion--first case report. Hepatogastroenterology 1998; 45 (20) 551-553
    PubMedGoogle Scholar
  • 14 Yamakado K, Nakatsuka A, Tanaka N. et al. Portal venous stent placement in patients with pancreatic and biliary neoplasms invading portal veins and causing portal hypertension: initial experience. Radiology 2001; 220 (01) 150-156
    CrossrefPubMedGoogle Scholar
  • 15 Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Terada N, Takeda K. Malignant portal venous obstructions treated by stent placement: significant factors affecting patency. J Vasc Interv Radiol 2001; 12 (12) 1407-1415
    CrossrefPubMedGoogle Scholar
  • 16 Mathias K, Bolder U, Löhlein D, Jäger H. Percutaneous transhepatic angioplasty and stent implantation for prehepatic portal vein obstruction. Cardiovasc Intervent Radiol 1993; 16 (05) 313-315
    CrossrefPubMedGoogle Scholar
  • 17 Burger JA, Ochs A, Wirth K. et al. The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients. Ann Oncol 1997; 8 (02) 200-202
    CrossrefPubMedGoogle Scholar
  • 18 Kaneoka Y, Yamaguchi A, Isogai M, Hori A. Intraportal stent placement combined with right portal vein embolization against advanced gallbladder carcinoma. Surg Today 1998; 28 (08) 862-865
    CrossrefPubMedGoogle Scholar
  • 19 Vogelzang RL, Reddy SG, Braun MA, Nemcek Jr AA. Extrahepatic portal venous stenosis: treatment with percutaneous transhepatic stent placement. J Vasc Interv Radiol 1996; 7 (02) 269-271
    CrossrefPubMedGoogle Scholar
  • 20 Hasegawa T, Yamakado K, Takaki H. et al. Portal venous stent placement for malignant portal venous stenosis or occlusion: who benefits?. Cardiovasc Intervent Radiol 2015; 38 (06) 1515-1522
    CrossrefPubMedGoogle Scholar
  • 21 Wu TT, Li HC, Li WM. et al. Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction: a safe and feasible method. Dig Dis Sci 2015; 60 (07) 2158-2163
    CrossrefPubMedGoogle Scholar
  • 22 Wu TT, Li HC, Zheng F, Ao GK, Lin H, Li WM. Percutaneous endovascular radiofrequency ablation for malignant portal obstruction: an initial clinical experience. Cardiovasc Intervent Radiol 2016; 39 (07) 994-1000
    CrossrefPubMedGoogle Scholar
  • 23 Wu TT, Li WM, Li HC, Ao GK, Zheng F, Lin H. Percutaneous intraductal radiofrequency ablation for extrahepatic distal cholangiocarcinoma: a method for prolonging stent patency and achieving better functional status and quality of life. Cardiovasc Intervent Radiol 2017; 40 (02) 260-269
    CrossrefPubMedGoogle Scholar
  • 24 Bilbao JI, Elorz M, Vivas I, Martínez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 2004; 27 (05) 474-480
    CrossrefPubMedGoogle Scholar
  • 25 Thornburg B, Desai K, Hickey R. et al. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort. J Vasc Interv Radiol 2017; 28 (12) 1714-1721.e2
    CrossrefPubMedGoogle Scholar
  • 26 Heyne JP, Pfleiderer SO, Trebing G, Scheele J, Kaiser WA. Palliative portal vein stent placement for lymphatic recurrence of gastric cancer. Int J Colorectal Dis 2005; 20 (01) 67-71
    CrossrefPubMedGoogle Scholar
  • 27 Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol 1999; 30 (04) 660-668
    CrossrefPubMedGoogle Scholar
  • 28 Novellas S, Denys A, Bize P. et al. Palliative portal vein stent placement in malignant and symptomatic extrinsic portal vein stenosis or occlusion. Cardiovasc Intervent Radiol 2009; 32 (03) 462-470
    CrossrefPubMedGoogle Scholar